• Home
  • Report
  • Points to consider in the preclinical development of immunomodulatory drugs...

Points to consider in the preclinical development of immunomodulatory drugs for the treatment of HIV infection and associated disorders

Center for Drug Evaluation and Research (Rockville, Md.) GND (edt.)

Files

Category

Date Issued:
1992
URN:
urn:nbn:de:gbv:084-11032410419
Language:
English
Type of Resource:
Text
Extent:
13 S.
Place Term:
Rockville, MD
Publisher:
Center for Drug Evaluation and Research (CDER)
Keywords:
ViFaPharm
DDC:
615 Pharmakologie, Therapie
URL:
http://www.digibib.tu-bs.de/?docid=00023955
Library shelfmark::
586164006

Cite

Citation style:

Points to consider in the preclinical development of immunomodulatory drugs for the treatment of HIV infection and associated disorders. Rockville, MD 1992. Center for Drug Evaluation and Research (CDER).

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

show details

Rights

Use and reproduction:
All rights reserved

Export

BibTeX, MODS, MARCXML, RIS, ISI, PICA, CSV, DC